These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2006 related items for PubMed ID: 15630071

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A pilot double-blind treatment trial of memantine for alcohol dependence.
    Evans SM, Levin FR, Brooks DJ, Garawi F.
    Alcohol Clin Exp Res; 2007 May; 31(5):775-82. PubMed ID: 17378918
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Divalproex utility in bipolar disorder with co-occurring cocaine dependence: a pilot study.
    Salloum IM, Douaihy A, Cornelius JR, Kirisci L, Kelly TM, Hayes J.
    Addict Behav; 2007 Feb; 32(2):410-5. PubMed ID: 16814474
    [Abstract] [Full Text] [Related]

  • 6. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study.
    Brady KT, Sonne SC, Anton R, Ballenger JC.
    J Clin Psychiatry; 1995 Mar; 56(3):118-21. PubMed ID: 7883730
    [Abstract] [Full Text] [Related]

  • 7. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S, Simojoki K, Virta A, Rosberg M, Löyttyniemi E, Nurminen T, Kallio A, Mäkelä R.
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [Abstract] [Full Text] [Related]

  • 8. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial.
    Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M.
    J Clin Psychiatry; 2010 Feb; 71(2):130-7. PubMed ID: 20122373
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E, Suppes T, Eggens I, Persson I, Paulsson B, Brecher M.
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [Abstract] [Full Text] [Related]

  • 12. Divalproex in the treatment of bipolar depression: a placebo-controlled study.
    Davis LL, Bartolucci A, Petty F.
    J Affect Disord; 2005 Apr; 85(3):259-66. PubMed ID: 15780695
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA, Hirschfeld RM, Ahearn EP, Weisler RH, Palmer C, Keck PE.
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
    Wilens TE, Adler LA, Weiss MD, Michelson D, Ramsey JL, Moore RJ, Renard D, Brady KT, Trzepacz PT, Schuh LM, Ahrbecker LM, Levine LR, Atomoxetine ADHD/SUD Study Group.
    Drug Alcohol Depend; 2008 Jul 01; 96(1-2):145-54. PubMed ID: 18403134
    [Abstract] [Full Text] [Related]

  • 16. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
    Martinotti G, Andreoli S, Di Nicola M, Di Giannantonio M, Sarchiapone M, Janiri L.
    Hum Psychopharmacol; 2008 Jul 01; 23(5):417-24. PubMed ID: 18425995
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 101.